Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. As opioids and tobacco continue to claim Hoosier lives, many are looking toward K-12 school-based prevention programs to stem the tide. One of the most well-known prevention programs is Drug Abuse Resistance Education, or D.A.R.E. At its height, D.A.R.E. was implemented across the world, with more than $750 million spent on the program annually. But study after study has found little evidence for the impacts of D.A.R.E. on drug use. This is a common problem: Keeping kids off drugs and alcohol is not easy. As a result, not every intervention works. The good news is […]

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. “Abusers.” “Reckless criminals.” These are the words of one pharmaceutical executive to describe the hundreds of thousands of Americans with opioid use disorder, uncovered in a wave of litigation facing the nation’s leading drug makers and sellers for their contributions to the opioid crisis. As these investigations bring more information to light, they are sure to change the way Americans think about the opioid epidemic. That’s good news. For too long, the stigma surrounding opioid use disorder has been a barrier to adopting public policies that treat the disease of addiction and prevent drug overdoses and death. Reluctance […]